JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)

CNY 9.85

(0.92%)

Net Income Summary of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest annual net income in 2023 was -71.94 Million CNY , up 8.03% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest quarterly net income in 2024 Q3 was 20.62 Million CNY , up 6.34% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported an annual net income of -78.23 Million CNY in 2022, down -444.38% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported an annual net income of 22.71 Million CNY in 2021, up 104.48% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported a quarterly net income of 5.05 Million CNY for 2024 Q1, up 106.1% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported a quarterly net income of 20.62 Million CNY for 2024 Q3, up 6.34% from previous quarter.

Annual Net Income Chart of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Historical Annual Net Income of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Year Net Income Net Income Growth
2023 -71.94 Million CNY 8.03%
2022 -78.23 Million CNY -444.38%
2021 22.71 Million CNY 104.48%
2020 -507.59 Million CNY -886.56%
2019 64.53 Million CNY 122.6%
2018 -285.56 Million CNY -314.54%
2017 133.1 Million CNY 84.88%
2016 71.99 Million CNY 46.59%
2015 49.11 Million CNY 20.23%
2014 40.84 Million CNY -19.17%
2013 50.53 Million CNY 7.9%
2012 46.83 Million CNY 51.74%
2011 30.86 Million CNY 5.34%
2010 29.3 Million CNY 101.15%
2009 14.56 Million CNY 112.65%
2008 6.85 Million CNY 110.65%
2007 -64.32 Million CNY -508.25%
2006 15.75 Million CNY -55.02%
2005 35.03 Million CNY -35.82%
2004 54.57 Million CNY 4.89%
2003 52.03 Million CNY -13.53%
2002 60.17 Million CNY -27.67%
2001 83.19 Million CNY 73.46%
2000 47.96 Million CNY 38.67%
1999 34.58 Million CNY 10.04%
1998 31.43 Million CNY 4.69%
1997 30.02 Million CNY -12.02%
1996 34.12 Million CNY 0.0%

Peer Net Income Comparison of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Name Net Income Net Income Difference
Beijing Tiantan Biological Products Co., Ltd. 1.1 Billion CNY 106.482%
Jinyu Bio-technology Co., Ltd. 283.63 Million CNY 125.366%
Vcanbio Cell & Gene Engineering Corp., Ltd 106.45 Million CNY 167.584%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 677.95 Million CNY 110.612%
Zhejiang Ausun Pharmaceutical Co., Ltd. 253.9 Million CNY 128.336%
DaShenLin Pharmaceutical Group Co., Ltd. 1.16 Billion CNY 106.168%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 1.24 Billion CNY 105.766%
GuiZhou SanLi Pharmaceutical Co.,Ltd 292.7 Million CNY 124.58%
Pulike Biological Engineering, Inc. 174.51 Million CNY 141.225%
Beijing Konruns Pharmaceutical Co.,Ltd. 150.45 Million CNY 147.82%
Shanghai Hile Bio-Technology Co., Ltd. 62.87 Million CNY 214.435%
Qingdao Vland Biotech INC. 80.7 Million CNY 189.144%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 254.48 Million CNY 128.271%
Aurisco Pharmaceutical Co.,Ltd. 289.41 Million CNY 124.858%
Zhejiang East Asia Pharmaceutical Co., Ltd. 121.24 Million CNY 159.337%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 106.49 Million CNY 167.556%
Mabwell (Shanghai) Bioscience Co., Ltd. -1.05 Billion CNY 93.17%
Beijing Hotgen Biotech Co., Ltd. 27.38 Million CNY 362.737%
Assure Tech (Hangzhou) Co., Ltd. 141.55 Million CNY 150.825%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 162.93 Million CNY 144.155%
Cabio Biotech (Wuhan) Co., Ltd. 91.37 Million CNY 178.737%
Shanghai Shen Lian Biomedical Corporation 31.51 Million CNY 328.262%
Nanjing Vazyme Biotech Co., Ltd. -70.95 Million CNY -1.394%
Shandong Kexing Bioproducts Co,.Ltd -190.29 Million CNY 62.192%
Shanghai Junshi Biosciences Co., Ltd. -2.28 Billion CNY 96.847%
Shanghai Model Organisms Center, Inc. -20.58 Million CNY -249.544%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. -278.58 Million CNY 74.175%
Xiamen Amoytop Biotech Co., Ltd. 555.44 Million CNY 112.953%
Novogene Co., Ltd. 178.05 Million CNY 140.405%
Shanghai ZJ Bio-Tech Co., Ltd. -136.85 Million CNY 47.43%
Chengdu Olymvax Biopharmaceuticals Inc. 17.55 Million CNY 509.814%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 294.61 Million CNY 124.42%
Shanghai Haohai Biological Technology Co., Ltd. 416.12 Million CNY 117.289%
Jiangsu Bioperfectus Technologies Co., Ltd. -373.81 Million CNY 80.754%
Jiangsu Aidea Pharmaceutical Co., Ltd. -76.06 Million CNY 5.422%
Chengdu Easton Biopharmaceuticals Co., Ltd. 226.57 Million CNY 131.753%
Sinocelltech Group Limited -396.01 Million CNY 81.833%
Wuhan Keqian Biology Co.,Ltd 395.93 Million CNY 118.171%
Shanghai Allist Pharmaceuticals Co., Ltd. 644.17 Million CNY 111.169%
Anhui Huaheng Biotechnology Co., Ltd. 449.06 Million CNY 116.021%
Youcare Pharmaceutical Group Co., Ltd. 184.79 Million CNY 138.932%
Jiangsu gdk Biotechnology Co., Ltd. -70.99 Million CNY -1.345%
Beijing Kawin Technology Share-Holding Co., Ltd. 116.52 Million CNY 161.742%
Hangzhou Biotest Biotech Co.,Ltd. 106.6 Million CNY 167.487%